Flagship Pioneering is an investment fund managing more than $2.38 billion ran by Noubar Ph.d.. There are currently 12 companies in Ph.d.’s portfolio. The largest investments include Moderna Inc and Sana Biotechnology Inc, together worth $1.73 billion.
$2.38 billion Assets Under Management (AUM)
As of 7th November 2022, Flagship Pioneering’s top holding is 12,886,743 shares of Moderna Inc currently worth over $1.52 billion and making up 64.1% of the portfolio value.Relative to the number of outstanding shares of Moderna Inc, Flagship Pioneering owns more than approximately 0.1% of the company.In addition, the fund holds 34,239,018 shares of Sana Biotechnology Inc worth $205 million. The third-largest holding is Seres Therapeutics Inc worth $148 million and the next is Omega Therapeutics Inc worth $140 million, with 25,902,269 shares owned.
Currently, Flagship Pioneering's portfolio is worth at least $2.38 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Flagship Pioneering
The Flagship Pioneering office and employees reside in Cambridge, Massachusetts. According to the last 13-F report filed with the SEC, Noubar Ph.d. serves as the Chief Executive Officer at Flagship Pioneering.
